Cargando…

Clinical-Immunological Correlates in Post-COVID-19 Endogenous Psychoses

Objectives. To carry out a clinical and immunological study of the potential impact of coronavirus infection on the course of endogenous psychoses. Materials and methods. A total of 33 female patients aged 16–48 years with depressive-delusional states (F20.01, F21, F31) developing after coronavirus...

Descripción completa

Detalles Bibliográficos
Autores principales: Zozulya, S. A., Sizov, S. V., Oleichik, I. V., Klyushnik, T. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063428/
https://www.ncbi.nlm.nih.gov/pubmed/37020644
http://dx.doi.org/10.1007/s11055-023-01405-9
_version_ 1785017703653703680
author Zozulya, S. A.
Sizov, S. V.
Oleichik, I. V.
Klyushnik, T. P.
author_facet Zozulya, S. A.
Sizov, S. V.
Oleichik, I. V.
Klyushnik, T. P.
author_sort Zozulya, S. A.
collection PubMed
description Objectives. To carry out a clinical and immunological study of the potential impact of coronavirus infection on the course of endogenous psychoses. Materials and methods. A total of 33 female patients aged 16–48 years with depressive-delusional states (F20.01, F21, F31) developing after coronavirus infections took part; group 1 consisted of 15 people who developed depressive-delusional states 1–2 months after COVID-19; group 2 consisted of 18 people with similar psychoses developing at later time points (2–6 months). The severity of psychopathological symptoms was assessed using the PANSS and HDRS-21 scales. The activity of inflammatory markers leukocyte elastase (LE) and α1-proteinase inhibitor (α1-PI) was determined in patients’ blood. Absolute neutrophil and lymphocyte contents and their ratio (the neutrophil:lymphocyte index) were also evaluated. Standard values for indicators from healthy donors corresponding to patients in terms of age and sex were used as control values. Results. Endogenous psychosis developing at longer intervals after coronavirus infection (group 2) was found to be associated with “typical” inflammatory reactions, with increases in the activity of acute-phase proteins (α1-PI: 43.0 (35.6–49.7) IU/ml, p = 0.001) and neutrophil degranulation activity (LE – 254.8 (238.0–271.0) nmol/min·ml, p < 0.001), which was associated with the development of depressive-delusional states with dominance of manifestations of positive affectivity (anxiety, melancholy) and the extended nature of delusional disorders, which were mostly incongruent to affect. Conversely, development of endogenous psychosis during the first two months after COVID-19 (group 1) was characterized by a spectrum of inflammatory biomarkers with a decrease in neutrophil count ((2.6 ± 0.9)·10(9)/liter, p < 0.05) and low LE activity (196 (172–209.4) nmol/min·ml, p < 0.001). This immunological profile was associated with predominance of manifestations of negative affectivity (apathy, asthenia, adynamia) in the structure of depressive-delusional states and the relatively undeveloped nature of delusional disorders, which were predominantly congruent to affect. Conclusions. The clinical and biological correlates found here presumptively indicate that experience of COVID-19 infection has a modulatory effect on neuroinflammation and the structure of endogenous psychosis.
format Online
Article
Text
id pubmed-10063428
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-100634282023-03-31 Clinical-Immunological Correlates in Post-COVID-19 Endogenous Psychoses Zozulya, S. A. Sizov, S. V. Oleichik, I. V. Klyushnik, T. P. Neurosci Behav Physiol Article Objectives. To carry out a clinical and immunological study of the potential impact of coronavirus infection on the course of endogenous psychoses. Materials and methods. A total of 33 female patients aged 16–48 years with depressive-delusional states (F20.01, F21, F31) developing after coronavirus infections took part; group 1 consisted of 15 people who developed depressive-delusional states 1–2 months after COVID-19; group 2 consisted of 18 people with similar psychoses developing at later time points (2–6 months). The severity of psychopathological symptoms was assessed using the PANSS and HDRS-21 scales. The activity of inflammatory markers leukocyte elastase (LE) and α1-proteinase inhibitor (α1-PI) was determined in patients’ blood. Absolute neutrophil and lymphocyte contents and their ratio (the neutrophil:lymphocyte index) were also evaluated. Standard values for indicators from healthy donors corresponding to patients in terms of age and sex were used as control values. Results. Endogenous psychosis developing at longer intervals after coronavirus infection (group 2) was found to be associated with “typical” inflammatory reactions, with increases in the activity of acute-phase proteins (α1-PI: 43.0 (35.6–49.7) IU/ml, p = 0.001) and neutrophil degranulation activity (LE – 254.8 (238.0–271.0) nmol/min·ml, p < 0.001), which was associated with the development of depressive-delusional states with dominance of manifestations of positive affectivity (anxiety, melancholy) and the extended nature of delusional disorders, which were mostly incongruent to affect. Conversely, development of endogenous psychosis during the first two months after COVID-19 (group 1) was characterized by a spectrum of inflammatory biomarkers with a decrease in neutrophil count ((2.6 ± 0.9)·10(9)/liter, p < 0.05) and low LE activity (196 (172–209.4) nmol/min·ml, p < 0.001). This immunological profile was associated with predominance of manifestations of negative affectivity (apathy, asthenia, adynamia) in the structure of depressive-delusional states and the relatively undeveloped nature of delusional disorders, which were predominantly congruent to affect. Conclusions. The clinical and biological correlates found here presumptively indicate that experience of COVID-19 infection has a modulatory effect on neuroinflammation and the structure of endogenous psychosis. Springer International Publishing 2023-03-31 2023 /pmc/articles/PMC10063428/ /pubmed/37020644 http://dx.doi.org/10.1007/s11055-023-01405-9 Text en © Springer Nature Switzerland AG 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Zozulya, S. A.
Sizov, S. V.
Oleichik, I. V.
Klyushnik, T. P.
Clinical-Immunological Correlates in Post-COVID-19 Endogenous Psychoses
title Clinical-Immunological Correlates in Post-COVID-19 Endogenous Psychoses
title_full Clinical-Immunological Correlates in Post-COVID-19 Endogenous Psychoses
title_fullStr Clinical-Immunological Correlates in Post-COVID-19 Endogenous Psychoses
title_full_unstemmed Clinical-Immunological Correlates in Post-COVID-19 Endogenous Psychoses
title_short Clinical-Immunological Correlates in Post-COVID-19 Endogenous Psychoses
title_sort clinical-immunological correlates in post-covid-19 endogenous psychoses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063428/
https://www.ncbi.nlm.nih.gov/pubmed/37020644
http://dx.doi.org/10.1007/s11055-023-01405-9
work_keys_str_mv AT zozulyasa clinicalimmunologicalcorrelatesinpostcovid19endogenouspsychoses
AT sizovsv clinicalimmunologicalcorrelatesinpostcovid19endogenouspsychoses
AT oleichikiv clinicalimmunologicalcorrelatesinpostcovid19endogenouspsychoses
AT klyushniktp clinicalimmunologicalcorrelatesinpostcovid19endogenouspsychoses